Baseline cfDNA concentration was numerically higher in patients with tumor sizes ≥3 cm compared to smaller tumors ( p = 0.49), though this did not reach statistical significance.
← all excerpts
Tracking response to neoadjuvant systemic therapy through circulating tumor DNA analysis in breast cancer.
1
—
—